Researchers from the Icahn Faculty at Mount Sinai studied the molecular basis of 5-MeO-DMT and its interaction with serotonin receptors, crucial for developing neuropsychiatric therapies.
5-MeO-DMT is being explored for treating depression, but its mechanism of action on the brain, particularly its impact on serotonin receptors, remains a focus of study for scientists.
Serotonin, a key neurotransmitter for mood regulation, is a vital factor in mental health. Low serotonin levels are linked to depression, and some antidepressants aim to raise these levels.
[
add
]
[
|
|
...
]